EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 166 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $227,000 | -3.0% | 5,433 | -1.5% | 0.01% | -11.1% |
| Q3 2020 | $234,000 | -8.2% | 5,515 | +3.9% | 0.01% | -10.0% |
| Q2 2020 | $255,000 | -25.4% | 5,306 | -28.6% | 0.01% | -23.1% |
| Q1 2020 | $342,000 | -52.8% | 7,436 | -38.3% | 0.01% | -43.5% |
| Q4 2019 | $724,000 | +40.9% | 12,056 | +32.8% | 0.02% | +35.3% |
| Q3 2019 | $514,000 | -4.6% | 9,080 | -6.2% | 0.02% | 0.0% |
| Q2 2019 | $539,000 | – | 9,681 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |